These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 33968019)

  • 1. Investigation of Extracellular Vesicles From SARS-CoV-2 Infected Specimens: A Safety Perspective.
    Nunez Lopez YO; Casu A; Pratley RE
    Front Immunol; 2021; 12():617042. PubMed ID: 33968019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular Vesicles Analysis in the COVID-19 Era: Insights on Serum Inactivation Protocols towards Downstream Isolation and Analysis.
    Frigerio R; Musicò A; Brucale M; Ridolfi A; Galbiati S; Vago R; Bergamaschi G; Ferretti AM; Chiari M; Valle F; Gori A; Cretich M
    Cells; 2021 Mar; 10(3):. PubMed ID: 33806297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 and Extracellular Vesicles: An Intriguing Interplay.
    Pocsfalvi G; Mammadova R; Ramos Juarez AP; Bokka R; Trepiccione F; Capasso G
    Kidney Blood Press Res; 2020; 45(5):661-670. PubMed ID: 32957112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic profiling of single extracellular vesicles reveals colocalization of SARS-CoV-2 with a CD81/integrin-rich EV subpopulation in sputum from COVID-19 severe patients.
    Sun R; Cai Y; Zhou Y; Bai G; Zhu A; Kong P; Sun J; Li Y; Liu Y; Liao W; Liu J; Cui N; Xiang J; Li B; Zhao J; Wu D; Ran P
    Front Immunol; 2023; 14():1052141. PubMed ID: 37251406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of viral inactivation methods on the characteristics of extracellular vesicles from SARS-CoV-2 infected human lung epithelial cells.
    Kongsomros S; Pongsakul N; Panachan J; Khowawisetsut L; Somkird J; Sangma C; Kanjanapruthipong T; Wongtrakoongate P; Chairoungdua A; Pattanapanyasat K; Newburg DS; Morrow AL; Hongeng S; Thitithanyanont A; Chutipongtanate S
    J Extracell Vesicles; 2022 Dec; 11(12):e12291. PubMed ID: 36468940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Therapeutic Effect of Micrornas in Extracellular Vesicles from Mesenchymal Stem Cells against SARS-CoV-2.
    Park JH; Choi Y; Lim CW; Park JM; Yu SH; Kim Y; Han HJ; Kim CH; Song YS; Kim C; Yu SR; Oh EY; Lee SM; Moon J
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of viral RNA fragments in human iPSC cardiomyocytes following treatment with extracellular vesicles from SARS-CoV-2 coding sequence overexpressing lung epithelial cells.
    Kwon Y; Nukala SB; Srivastava S; Miyamoto H; Ismail NI; Jousma J; Rehman J; Ong SB; Lee WH; Ong SG
    Stem Cell Res Ther; 2020 Nov; 11(1):514. PubMed ID: 33256833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential therapeutic applications of extracellular vesicles in the immunopathogenesis of COVID-19.
    Motallebnezhad M; Omraninava M; Esmaeili Gouvarchin Ghaleh H; Jonaidi-Jafari N; Hazrati A; Malekpour K; Bagheri Y; Izadi M; Ahmadi M
    Pathol Res Pract; 2023 Jan; 241():154280. PubMed ID: 36580795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and infectivity potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) environmental contamination in isolation units and quarantine facilities.
    Ben-Shmuel A; Brosh-Nissimov T; Glinert I; Bar-David E; Sittner A; Poni R; Cohen R; Achdout H; Tamir H; Yahalom-Ronen Y; Politi B; Melamed S; Vitner E; Cherry L; Israeli O; Beth-Din A; Paran N; Israely T; Yitzhaki S; Levy H; Weiss S
    Clin Microbiol Infect; 2020 Dec; 26(12):1658-1662. PubMed ID: 32919072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
    Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meet changes with constancy: Defence, antagonism, recovery, and immunity roles of extracellular vesicles in confronting SARS-CoV-2.
    Chen X; Li H; Song H; Wang J; Zhang X; Han P; Wang X
    J Extracell Vesicles; 2022 Dec; 11(12):e12288. PubMed ID: 36450704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Putative Roles for Peptidylarginine Deiminases in COVID-19.
    Arisan ED; Uysal-Onganer P; Lange S
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32629995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of SARS-CoV-2 infectivity of upper respiratory specimens from COVID-19 patients by virus isolation using VeroE6/TMPRSS2 cells.
    Yamada S; Fukushi S; Kinoshita H; Ohnishi M; Suzuki T; Fujimoto T; Saijo M; Maeda K;
    BMJ Open Respir Res; 2021 Feb; 8(1):. PubMed ID: 33627333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Untargeted Metabolic Profiling of Extracellular Vesicles of SARS-CoV-2-Infected Patients Shows Presence of Potent Anti-Inflammatory Metabolites.
    Alzahrani FA; Shait Mohammed MR; Alkarim S; Azhar EI; El-Magd MA; Hawsawi Y; Abdulaal WH; Yusuf A; Alhatmi A; Albiheyri R; Fakhurji B; Kurdi B; Madani TA; Alguridi H; Alosaimi RS; Khan MI
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deposition distribution of the new coronavirus (SARS-CoV-2) in the human airways upon exposure to cough-generated droplets and aerosol particles.
    Madas BG; Füri P; Farkas Á; Nagy A; Czitrovszky A; Balásházy I; Schay GG; Horváth A
    Sci Rep; 2020 Dec; 10(1):22430. PubMed ID: 33384436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymptomatic COVID-19 Patients Can Contaminate Their Surroundings: an Environment Sampling Study.
    Wei L; Lin J; Duan X; Huang W; Lu X; Zhou J; Zong Z
    mSphere; 2020 Jun; 5(3):. PubMed ID: 32581071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procedures for Flow Cytometry-Based Sorting of Unfixed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Cells and Other Infectious Agents.
    Reifel KM; Swan BK; Jellison ER; Ambrozak D; Baijer J; Nguyen R; Monard S; Lyon G; Fontes B; Perfetto SP
    Cytometry A; 2020 Jul; 97(7):674-680. PubMed ID: 32488957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating extracellular vesicles are endowed with enhanced procoagulant activity in SARS-CoV-2 infection.
    Balbi C; Burrello J; Bolis S; Lazzarini E; Biemmi V; Pianezzi E; Burrello A; Caporali E; Grazioli LG; Martinetti G; Fusi-Schmidhauser T; Vassalli G; Melli G; Barile L
    EBioMedicine; 2021 May; 67():103369. PubMed ID: 33971404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.
    Ye C; Chiem K; Park JG; Oladunni F; Platt RN; Anderson T; Almazan F; de la Torre JC; Martinez-Sobrido L
    mBio; 2020 Sep; 11(5):. PubMed ID: 32978313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Extracellular Vesicles in COVID-19 Pathology.
    Tahyra ASC; Calado RT; Almeida F
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.